Efficacy of oral prolonged-release mesalazine in moderately active ulcerative colitis.
Kristine ParidaensJohn R FullartonSimon P L TravisPublished in: JGH open : an open access journal of gastroenterology and hepatology (2023)
New meta-analyses are presented that provide further evidence supporting the effectiveness of oral prolonged-release mesalazine compared to other oral mesalazines as induction therapy in patients with moderately active ulcerative colitis.